{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,26]],"date-time":"2025-10-26T21:32:40Z","timestamp":1761514360767,"version":"build-2065373602"},"reference-count":33,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2019,8,1]],"date-time":"2019-08-01T00:00:00Z","timestamp":1564617600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,8,1]],"date-time":"2019-08-01T00:00:00Z","timestamp":1564617600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2019,3,6]],"date-time":"2019-03-06T00:00:00Z","timestamp":1551830400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/100007186","name":"Jonsson Comprehensive Cancer Center","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100007186","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Safeway Foundation"}],"content-domain":{"domain":["clinical-breast-cancer.com","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Clinical Breast Cancer"],"published-print":{"date-parts":[[2019,8]]},"DOI":"10.1016\/j.clbc.2019.02.009","type":"journal-article","created":{"date-parts":[[2019,3,11]],"date-time":"2019-03-11T02:55:15Z","timestamp":1552272915000},"page":"246-253.e2","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":9,"title":["Implementing a Population-Based Breast Cancer Risk Assessment Program"],"prefix":"10.1016","volume":"19","author":[{"given":"Erica","family":"Silver","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Neil","family":"Wenger","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zhuoer","family":"Xie","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"David","family":"Elashoff","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kristina","family":"Lee","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lisa","family":"Madlensky","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jacqueline","family":"Trent","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Antonia","family":"Petruse","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Liliana","family":"Johansen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Arash","family":"Naeim","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.clbc.2019.02.009_bib1","doi-asserted-by":"crossref","first-page":"2955","DOI":"10.1002\/cncr.28771","article-title":"Breast cancer screening in an era of personalized regimens: a conceptual model and National Cancer Institute initiative for risk-based and preference-based approaches at a population level","volume":"120","author":"Onega","year":"2014","journal-title":"Cancer"},{"key":"10.1016\/j.clbc.2019.02.009_bib2","doi-asserted-by":"crossref","first-page":"1652","DOI":"10.1093\/jnci\/dji372","article-title":"Tamoxifen for the prevention of breast cancer: current status of the National Surgical Adjuvant Breast and Bowel Project P-1 Study","volume":"97","author":"Fisher","year":"2005","journal-title":"J\u00a0Natl Cancer Inst"},{"key":"10.1016\/j.clbc.2019.02.009_bib3","doi-asserted-by":"crossref","first-page":"2727","DOI":"10.1001\/jama.295.23.joc60074","article-title":"Effects of tamoxifen vs raloxifene on the risk of developing invasive breast cancer and other disease outcomes: the NSABP Study of Tamoxifen and Raloxifene (STAR) P-2 trial","volume":"295","author":"Vogel","year":"2006","journal-title":"JAMA"},{"key":"10.1016\/j.clbc.2019.02.009_bib4","doi-asserted-by":"crossref","first-page":"2381","DOI":"10.1056\/NEJMoa1103507","article-title":"Exemestane for breast-cancer prevention in postmenopausal women","volume":"364","author":"Goss","year":"2011","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.clbc.2019.02.009_bib5","first-page":"CD002748","article-title":"Prophylactic mastectomy for the prevention of breast cancer","author":"Lostumbo","year":"2010","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.clbc.2019.02.009_bib6","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1053\/j.sult.2011.03.005","article-title":"Magnetic resonance imaging and breast ultrasonography as an adjunct to mammographic screening in high-risk patients screening breast magnetic resonance imaging","volume":"32","author":"Le-Petross","year":"2011","journal-title":"Semin Ultrasound CT MR"},{"key":"10.1016\/j.clbc.2019.02.009_bib7","first-page":"174","article-title":"The comprehensiveness of family cancer history assessments in primary care","volume":"10","author":"Murff","year":"2007","journal-title":"Community Genet"},{"key":"10.1016\/j.clbc.2019.02.009_bib8","first-page":"1","article-title":"Collection and use of cancer family history in primary care","author":"Qureshi","year":"2007","journal-title":"Evid Rep Technol Assess (Full Rep)"},{"key":"10.1016\/j.clbc.2019.02.009_bib9","doi-asserted-by":"crossref","first-page":"788","DOI":"10.1093\/jnci\/djr114","article-title":"Confirmation of family cancer history reported in a population-based survey","volume":"103","author":"Mai","year":"2011","journal-title":"J\u00a0Natl Cancer Inst"},{"key":"10.1016\/j.clbc.2019.02.009_bib10","first-page":"239","article-title":"Cancer risk assessment: quality and impact of the Family History Interview","volume":"27","author":"Murff","year":"2004","journal-title":"Am J Prev Med"},{"key":"10.1016\/j.clbc.2019.02.009_bib11","doi-asserted-by":"crossref","first-page":"286","DOI":"10.1093\/jnci\/87.4.286","article-title":"Effects of individualized breast cancer risk counseling: a randomized trial","volume":"87","author":"Lerman","year":"1995","journal-title":"J\u00a0Natl Cancer Inst"},{"key":"10.1016\/j.clbc.2019.02.009_bib12","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1093\/fampra\/18.2.135","article-title":"Guidelines for referral to a regional genetics service: GPs respond by referring more appropriate cases","volume":"18","author":"Lucassen","year":"2001","journal-title":"Fam Pract"},{"key":"10.1016\/j.clbc.2019.02.009_bib13","doi-asserted-by":"crossref","first-page":"1879","DOI":"10.1093\/jnci\/81.24.1879","article-title":"Projecting individualized probabilities of developing breast cancer for white females who are being examined annually","volume":"81","author":"Gail","year":"1989","journal-title":"J\u00a0Natl Cancer Inst"},{"key":"10.1016\/j.clbc.2019.02.009_bib14","doi-asserted-by":"crossref","first-page":"1111","DOI":"10.1002\/sim.1668","article-title":"A\u00a0breast cancer prediction model incorporating familial and personal risk factors","volume":"23","author":"Tyrer","year":"2004","journal-title":"Stat Med"},{"key":"10.1016\/j.clbc.2019.02.009_bib15","doi-asserted-by":"crossref","first-page":"1580","DOI":"10.1038\/sj.bjc.6602175","article-title":"The BOADICEA model of genetic susceptibility to breast and ovarian cancer","volume":"91","author":"Antoniou","year":"2004","journal-title":"Br J Cancer"},{"key":"10.1016\/j.clbc.2019.02.009_bib16","first-page":"232","article-title":"Genetic analysis of breast cancer in the cancer and steroid hormone study","volume":"48","author":"Claus","year":"1991","journal-title":"Am J Hum Genet"},{"key":"10.1016\/j.clbc.2019.02.009_bib17","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1086\/301670","article-title":"Determining carrier probabilities for breast cancer-susceptibility genes BRCA1 and BRCA2","volume":"62","author":"Parmigiani","year":"1998","journal-title":"Am J Hum Genet"},{"key":"10.1016\/j.clbc.2019.02.009_bib18","first-page":"1479","article-title":"Modeling familial clustered breast cancer using published data","volume":"12","author":"Jonker","year":"2003","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"key":"10.1016\/j.clbc.2019.02.009_bib19","doi-asserted-by":"crossref","first-page":"R144","DOI":"10.1186\/bcr3352","article-title":"Breast cancer risk assessment across the risk continuum: genetic and nongenetic risk factors contributing to differential model performance","volume":"14","author":"Quante","year":"2012","journal-title":"Breast Cancer Res"},{"key":"10.1016\/j.clbc.2019.02.009_bib20","doi-asserted-by":"crossref","first-page":"807","DOI":"10.1136\/jmg.40.11.807","article-title":"Evaluation of breast cancer risk assessment packages in the family history evaluation and screening programme","volume":"40","author":"Amir","year":"2003","journal-title":"J\u00a0Med Genet"},{"key":"10.1016\/j.clbc.2019.02.009_bib21","doi-asserted-by":"crossref","first-page":"680","DOI":"10.1093\/jnci\/djq088","article-title":"Assessing women at high risk of breast cancer: a review of risk assessment models","volume":"102","author":"Amir","year":"2010","journal-title":"J\u00a0Natl Cancer Inst"},{"key":"10.1016\/j.clbc.2019.02.009_bib22","doi-asserted-by":"crossref","first-page":"1541","DOI":"10.1093\/jnci\/91.18.1541","article-title":"Validation studies for models projecting the risk of invasive and total breast cancer incidence","volume":"91","author":"Costantino","year":"1999","journal-title":"J\u00a0Natl Cancer Inst"},{"key":"10.1016\/j.clbc.2019.02.009_bib23","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1007\/s10549-013-2612-0","article-title":"The Athena Breast Health Network: developing a rapid learning system in breast cancer prevention, screening, treatment, and care","volume":"140","author":"Elson","year":"2013","journal-title":"Breast Cancer Res Treat"},{"key":"10.1016\/j.clbc.2019.02.009_bib24","doi-asserted-by":"crossref","first-page":"271","DOI":"10.7326\/M13-2747","article-title":"Risk assessment, genetic counseling, and genetic testing for BRCA-related cancer in women: U.S. Preventive Services Task Force Recommendation Statement","volume":"160","author":"Moyer","year":"2014","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.clbc.2019.02.009_bib25","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1200\/JOP.2010.000107","article-title":"Implementation in a large health system of a program to identify women at high risk for breast cancer","volume":"7","author":"Owens","year":"2011","journal-title":"J\u00a0Oncol Pract"},{"key":"10.1016\/j.clbc.2019.02.009_bib26","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1016\/j.clbc.2012.03.002","article-title":"Implementation and outcomes of a multidisciplinary high-risk breast cancer program: the William Beaumont Hospital experience","volume":"12","author":"Shah","year":"2012","journal-title":"Clin Breast Cancer"},{"key":"10.1016\/j.clbc.2019.02.009_bib27","first-page":"I","article-title":"Summaries for patients. Using medications to decrease the risk for breast cancer in women: recommendations from the U.S. Preventive Services Task Force","volume":"159","year":"2013","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.clbc.2019.02.009_bib28","doi-asserted-by":"crossref","first-page":"2942","DOI":"10.1200\/JCO.2013.49.3122","article-title":"Use of pharmacologic interventions for breast cancer risk reduction: American Society of Clinical Oncology clinical practice guideline","volume":"31","author":"Visvanathan","year":"2013","journal-title":"J\u00a0Clin Oncol"},{"key":"10.1016\/j.clbc.2019.02.009_bib29","doi-asserted-by":"crossref","first-page":"880","DOI":"10.6004\/jnccn.2015.0105","article-title":"Breast cancer risk reduction, Version 2.2015","volume":"13","author":"Bevers","year":"2015","journal-title":"J\u00a0Natl Compr Canc Netw"},{"key":"10.1016\/j.clbc.2019.02.009_bib30","doi-asserted-by":"crossref","first-page":"927","DOI":"10.6004\/jnccn.2015.0107","article-title":"Barriers to the use of breast cancer risk reduction therapies","volume":"13","author":"Bambhroliya","year":"2015","journal-title":"J\u00a0Natl Compr Canc Netw"},{"key":"10.1016\/j.clbc.2019.02.009_bib31","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1016\/j.ypmed.2004.09.041","article-title":"Factors affecting breast cancer risk reduction practices among California physicians","volume":"41","author":"Kaplan","year":"2004","journal-title":"Prev Med"},{"key":"10.1016\/j.clbc.2019.02.009_bib32","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1016\/j.cdp.2007.08.003","article-title":"Breast cancer risk assessment and management in primary care: provider attitudes, practices, and barriers","volume":"31","author":"Sabatino","year":"2007","journal-title":"Cancer Detect Prev"},{"key":"10.1016\/j.clbc.2019.02.009_bib33","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1016\/j.breast.2014.11.006","article-title":"Acceptance and adherence to chemoprevention among women at increased risk of breast cancer","volume":"24","author":"Roetzheim","year":"2015","journal-title":"Breast"}],"container-title":["Clinical Breast Cancer"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1526820918307614?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1526820918307614?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,26]],"date-time":"2025-10-26T21:17:55Z","timestamp":1761513475000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1526820918307614"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,8]]},"references-count":33,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2019,8]]}},"alternative-id":["S1526820918307614"],"URL":"https:\/\/doi.org\/10.1016\/j.clbc.2019.02.009","relation":{},"ISSN":["1526-8209"],"issn-type":[{"type":"print","value":"1526-8209"}],"subject":[],"published":{"date-parts":[[2019,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Implementing a Population-Based Breast Cancer Risk Assessment Program","name":"articletitle","label":"Article Title"},{"value":"Clinical Breast Cancer","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.clbc.2019.02.009","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 The Authors. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}